Brief: Atomo Diagnostics Says Co And Ng Biotech Sign New Commercialisation Agreement
18/01/2023 24:50
Jan 18 (Reuters) - Atomo Diagnostics Ltd AT1.AX :
* CO AND NG BIOTECH SIGN NEW COMMERCIALISATION AGREEMENT
* UNDER AGREEMENT, CO WILL CONTINUE TO SUPPLY NG BIOTECH
WITH
ASSEMBLED PASCAL DEVICES, AMONG OTHERS
Source text for Eikon: ID:nASXbTM1HJ
Further company coverage: AT1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt